Phase II Trial for Stage III and IVa Head and Neck Cancer

image2
Dr. Joel Tepper

Joel Tepper, M.D. and colleagues have published an article entitled Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer published in the March 15, 2011 issue of the International Journal of Radiation Oncology•Biology•Physics (Volume 79, Number 4).